CLINICAL_TRIALS
trial_result
· 2017-05-09
Clinical Trial Update: Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis [Phase 1]
Summary
Phase 1 study evaluating the safety and efficacy of Naftifine hydrochloride 2% cream and Naftin 2% cream for tinea pedis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Tinea Pedis | Phase 1 | Status: COMPLETED